Claims for acne, eczema and psoriasis are common on social video and largely uncited; a 2025 analysis found most promoting posts showed financial bias.
Ancestral skincare — tallow is bio-identical to human sebum, so it heals acne, eczema and psoriasis where lab-made creams cannot.
The market's own words. No brand is named, because the claim is the thing under examination and it belongs to dozens of them.
In people with acne, atopic dermatitis or psoriasis, does topical beef tallow, compared with an ordinary emollient, improve a validated severity score over at least four weeks?
The same claim written as a proposition somebody could go and check: who, compared with what, measured how, over how long.
What kind of missing this is
Nobody has run the study. Not a small study, not a weak study, not a study with the wrong endpoint. None.
The strongest study is not about tallow. It is about the people selling it, and it is more informative than a small trial would have been.
Almatroud and colleagues, in the Journal of Cosmetic Dermatology in December 2025, ran a cross-sectional analysis of beef tallow skincare content across YouTube, Instagram and TikTok. Their findings, in their own words: claims of efficacy for acne, atopic dermatitis and psoriasis were prevalent but largely lacked cited evidence, and the majority of posts promoting beef tallow across platforms demonstrated financial bias and were uploaded by individuals lacking credentials in healthcare. Their conclusion: despite growing anecdotal claims that beef tallow benefits skincare and dermatologic conditions, evidence remains insufficient to support these claims. The authors themselves call for further work on long-term effects, formulations and suitability across conditions.
What is not there is any trial. No randomized comparison, no split-face study, no cohort. For three named conditions with validated severity scales and decades of trial infrastructure, nobody has run anything.
On the mechanism most often cited: tallow's fatty-acid profile does resemble human sebum in broad terms. That is a real observation and it is also where the argument stops, because resemblance to sebum is not obviously desirable in acne — sebum is part of the problem in acne, not the remedy — and no study has tested whether the resemblance produces any clinical benefit.
A randomized, assessor-blinded trial in at least 100 people with mild-to-moderate atopic dermatitis, comparing a standardized, preserved tallow preparation against a standard emollient over four weeks, with EASI or SCORAD as the primary endpoint and transepidermal water loss alongside it.
Atopic dermatitis first, because it is where an occlusive emollient has the most plausible mechanism and the cleanest measurement tools. Acne second, and separately, because the mechanism there points the other way and lumping the two together is one of the things the marketing does.
Standardized and preserved, because rendered fat varies by animal, diet, rendering temperature and storage, and a positive result from one person's jar is a result about that jar.
One such trial showing non-inferiority to a standard emollient would move this to Partially established, for the narrow and entirely reasonable claim that tallow works as an emollient. That is a claim I would expect to survive. It is a long way from healing psoriasis.
It does not mean tallow is harmful. It is fat, it is occlusive, and the safety questions worth having are about preservation and rancidity rather than about the substance.
It does not mean it will not moisturize you. It almost certainly will. Occlusives work, and an unproven occlusive is still an occlusive.
It does not mean everyone whose eczema improved is wrong. Eczema remits and relapses on its own, and anybody who switches to a heavy occlusive after months of a light lotion has changed something real about their barrier care, whatever the jar contained.
And it does not mean the people making it are cynical. Most of them believe it. The cited analysis found financial bias, which is a statement about disclosed interest, not about sincerity.
You are paying for rendered fat, sometimes at prices well above a pharmacy emollient with a full clinical file behind it, and often from a seller with no manufacturing or safety framework.
What you are not paying for is a treatment. There is no trial for any of the three conditions the claim names.
What you may well get is a decent occlusive, and if what your skin needed was a decent occlusive, you will be pleased. That is worth stating without sneering, because the ancestral framing attracts a lot of condescension it does not entirely deserve — people are usually reaching for tallow after something else stopped working.
Two practical things. Buy from somebody who preserves and dates it, because unpreserved animal fat goes off and it will not tell you politely. And if you have active acne, the sebum-resemblance argument is the reason to be cautious, not the reason to buy — that is the one place the proposed mechanism argues against the claim.
Type and funding are stated because they change what a study is allowed to prove, and because a trial paid for by the company selling the thing is not disqualified — it is just not the same evidence as one that was not.